Download full-text PDF |
Source |
---|
Front Oncol
September 2024
Department of Hepatobiliary Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
Front Endocrinol (Lausanne)
June 2024
Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Objective: Individuals with hypopituitarism (HPs) have an increased risk of developing non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) due to growth hormone deficiency (GHD). We aimed to investigate the possible mechanisms underlying the relationship between GHD and NAFLD using proteomic and metabolomic insights.
Methods: Serum metabolic alternations were assessed in male HPs using untargeted metabolomics.
Growth Horm IGF Res
June 2024
Pituitary Tumor Unit, Endocrinology Department, Hospital CUF Descobertas, Lisbon, Portugal; Faculdade de Medicina, Universidade Católica Portuguesa, Lisbon, Portugal. Electronic address:
Key Clinical Message: Our case highlights the importance of recognizing acromegaly as a potential risk factor for venous thromboembolism (VTE). Despite a thorough thrombophilia workup yielding unremarkable results, further research is warranted to elucidate the underlying mechanisms linking acromegaly and thrombophilia. This understanding will aid in improving risk assessment and management strategies for patients with acromegaly.
View Article and Find Full Text PDFEndocrinol Diabetes Metab Case Rep
January 2024
Department of Diabetes and Endocrinology, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!